Evidence map›Paper›PMID 42711527›Full record

ArticleNature immunology2026

New frontiers in pathogen immunity.

Mauro Gaya, Mads Gyrd-Hansen, Anna Kajaste-Rudnitski, Matteo Iannacone, Nicolas Manel, Jonathan N Pruneda, Jan Rehwinkel, Annemarthe G van der Veen

Abstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mauro GayaCentre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille, France.
Mads Gyrd-HansenLEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-5641-5019
Anna Kajaste-RudnitskiDepartment of Biology and Biotechnology, University of Pavia, Pavia, Italy.
Matteo IannaconeInstitute of Immunology and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID http://orcid.org/0000-0002-9370-2671
Nicolas ManelInstitut Curie, PSL University, INSERM U932, Immunity and Cancer, Paris, France.ORCID http://orcid.org/0000-0002-1481-4430
Jonathan N PrunedaDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0002-0304-4418
Jan RehwinkelMRC Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Annemarthe G van der VeenLeiden University Medical Centre, Department of Immunology, Leiden, The Netherlands. A.G.van_der_Veen@lumc.nl.ORCID http://orcid.org/0000-0001-9324-3404

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42711527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.